Meanwhile, ER+ breast cancer cells can also produce EVs loaded with miR-19a, and promote osteolytic bone metastasis by inhibiting PTEN expression and inducing NF-κB and AKT pathways (41). Here, NFKB1 is linked to breast cancer.